ISLAMABAD: After a gap of more than six months, the Higher Education Commission (HEC) finally has a chairman, as Prof Dr Niaz Ahmad Akhtar (Sitara-i-Imtiaz) assumed office on Friday with what he ...
Real-time data can also be captured by drones during and after flood events. Another technology used is a modeling program called ICM that’s used for large watersheds. It will model underground flow ...
ISLAMABAD: Vice Chancellor Quaid-i-Azam University Prof Dr Niaz Ahmad Akhtar is likely to be new Chairman Higher Education Commission (HEC). Reliable sources said that name of Dr Niaz has almost been ...
Downers Grove, Ill.-based AllTranstek LLC has acquired the assets of Darien, Ill.-based RAS Data Services (RAS), following its identification last month as the prevailing auction bidder. AllTranstek, ...
Oxaliplatin-induced portal hypertension in colorectal cancer: A systematic review of incidence, mechanisms, and predictive markers. This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal ...
A comprehensive, modular Python automation system for HEC-RAS flood analysis workflows. This professional-grade tool demonstrates advanced hydraulic modeling capabilities, Python integration, and ...
The Washington State Department of Transportation is now offering an online open house with information, including traffic impacts that could interrupt highway traffic for weeks, about a multi-year ...
Construction crews remove and replace a culvert on southbound Highway 101 near Dos Pueblos Canyon Road west of Goleta. One lane will be closed in the area through mid-October. Credit: Caltrans ...
Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...
BUHL, Idaho — A 15-year-old girl was hospitalized Saturday evening after being swept into a drainage culvert while visiting a popular kayaking area with her family. According to the Twin Falls County ...
Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.